DZIF

Contact
dzif.de
+49 5316181 1152

Deutsches Zentrum für Infektionsforschung e.V.

Inhoffenstraße 7
38124 Braunschweig
Germany
+49 5316181 1152
dzif.de
Contact
Profile News
Contact

About DZIF

Read more about DZIF
Facts about DZIF
  • Industry : Healthcare

News about DZIF

DZIF

28-May-2026 | science

Heidelberg-based development revolutionizes hepatitis D therapy worldwide

FDA approves hepatitis drug Hepcludex

Read news
DZIF

20-Apr-2026 | science

Artificial insemination: combination of bacteria could predict success

Common tests lack a basis

Read news
DZIF

01-Apr-2026 | science

Development of a rapid test for diagnosing hard-to-treat VRE Bacteria

Vancomycin-resistant Enterococcus faecium (VRE) is among the most concerning antibiotic-resistant pathogens, as treatment options are severely limited. The ...

Read news
DZIF

17-Sep-2025 | science

How HIV enters the genome – Researchers identify previously unknown mechanism

The results provide new therapeutic approaches for specifically controlling HIV reservoirs in the body

Read news
DZIF

23-Jul-2025 | science

Data-driven detection of concerning SARS-CoV-2 variants months in Advance

Online tool can detect and characterize SARS-CoV-2 Variants of Concern up to three months before their formal designation of the WHO

Read news
DZIF

05-Jun-2025 | science

Broad-spectrum antiviral compounds discovered

Computer-identified drug candidates successfully confirmed by laboratory experiments

Read news
DZIF

15-Apr-2025 | science

Gut microbiome as a predictive factor for kidney rejection?

Study establishes a link between microbial changes in the gut microbiome and transplant rejection and graft dysfunction

Read news
DZIF

18-Dec-2024 | business & finance

Start-up EBViously founded

Innovative vaccine based on virus-like particles

Read news
DZIF

26-Nov-2024 | science

An innovative antibiotic class for drug-resistant bacteria

New active compounds inspired by a bacterium

Read news
DZIF

23-Oct-2024 | science

Chemical trick activates antibiotic directly at the pathogen

Click-to-release technique avoids the severely nephrotoxic effect of colistin

Read news
DZIF

22-Aug-2024 | science

New vector vaccine against COVID-19 provides long-term protection

Established vaccines against COVID-19 are known to have the disadvantage that the initially good protective effect wears off relatively quickly. This makes ...

Read news
DZIF

02-May-2024 | science

New mode of action in the "bacterial war" decoded: Possible alternative to antibiotics produced by bacteria

Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors

Read news
DZIF

24-Aug-2023 | science

Researchers decode new antibiotic

Combined attack minimizes resistance development

Read news
DZIF

08-Aug-2023 | science

A promising investigational therapeutic monoclonal antibody to treat chronic hepatitis B and D infections

Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical ...

Read news
DZIF

13-Jun-2023 | science

How the gut microbiome responds to antibiotics

Antibiotics affect the composition and dynamics of the gut microbiome. Treatment with antibiotics not only leads to a loss of biodiversity of microorganisms ...

Read news
Show more news about DZIF

Here you will find Deutsches Zentrum für Infektionsforschung e.V.

Last viewed contents

CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate - On track to initiate pivotal Phase 2b/3 before end of 2020

CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate - On track to initiate pivotal Phase 2b/3 before end of 2020

Go to page

Novozymes Biopharma secures CPhI 2009 innovation award for its albufuse technology

Go to page
Liver cells grown from patients' skin cells - Treatment of liver diseases possible

Liver cells grown from patients' skin cells - Treatment of liver diseases possible

Go to page